Shares of Innophos Holdings, Inc. (NASDAQ:IPHS) have been given an average broker rating score of 2.00 (Buy) from the two analysts that provide coverage for the company, Zacks Investment Research reports. One analyst has rated the stock with a hold rating and one has assigned a strong buy rating to the company.

Brokers have set a 1 year consensus price target of $48.00 for the company and are forecasting that the company will post $0.35 earnings per share for the current quarter, according to Zacks. Zacks has also assigned Innophos an industry rank of 161 out of 256 based on the ratings given to its competitors.

Several research firms have recently weighed in on IPHS. Zacks Investment Research raised shares of Innophos from a “sell” rating to a “hold” rating in a report on Tuesday, April 30th. BidaskClub raised shares of Innophos from a “sell” rating to a “hold” rating in a report on Friday, March 29th. TheStreet raised shares of Innophos from a “c” rating to a “b-” rating in a report on Thursday, February 21st. Seaport Global Securities began coverage on shares of Innophos in a report on Thursday, February 21st. They set a “buy” rating for the company. Finally, ValuEngine raised shares of Innophos from a “strong sell” rating to a “sell” rating in a report on Monday, February 4th.

A number of hedge funds and other institutional investors have recently modified their holdings of IPHS. Segall Bryant & Hamill LLC boosted its holdings in Innophos by 48.3% in the 4th quarter. Segall Bryant & Hamill LLC now owns 1,707,840 shares of the specialty chemicals company’s stock worth $41,893,000 after buying an additional 556,531 shares during the period. American Century Companies Inc. raised its holdings in shares of Innophos by 24.6% during the fourth quarter. American Century Companies Inc. now owns 905,016 shares of the specialty chemicals company’s stock valued at $22,200,000 after purchasing an additional 178,826 shares during the last quarter. Deprince Race & Zollo Inc. increased its holdings in Innophos by 40.7% during the fourth quarter. Deprince Race & Zollo Inc. now owns 612,289 shares of the specialty chemicals company’s stock valued at $15,019,000 after buying an additional 177,149 shares during the last quarter. Assenagon Asset Management S.A. purchased a new stake in Innophos during the fourth quarter valued at approximately $3,847,000. Finally, Hotchkis & Wiley Capital Management LLC purchased a new stake in Innophos during the first quarter valued at approximately $4,277,000. 91.18% of the stock is owned by institutional investors.

Shares of IPHS traded up $0.01 during midday trading on Friday, hitting $30.33. The stock had a trading volume of 401 shares, compared to its average volume of 91,471. Innophos has a twelve month low of $22.57 and a twelve month high of $50.40. The company has a market capitalization of $596.98 million, a price-to-earnings ratio of 13.22 and a beta of 1.33. The company has a debt-to-equity ratio of 0.95, a current ratio of 3.14 and a quick ratio of 1.49.

Innophos (NASDAQ:IPHS) last issued its quarterly earnings data on Tuesday, April 30th. The specialty chemicals company reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.14. The company had revenue of $191.41 million for the quarter, compared to analysts’ expectations of $199.90 million. Innophos had a net margin of 4.30% and a return on equity of 13.09%. Innophos’s revenue for the quarter was down 6.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.61 earnings per share. Sell-side analysts anticipate that Innophos will post 2.36 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, June 7th. Stockholders of record on Friday, May 17th will be issued a dividend of $0.48 per share. This represents a $1.92 annualized dividend and a dividend yield of 6.33%. The ex-dividend date of this dividend is Thursday, May 16th. Innophos’s dividend payout ratio (DPR) is 84.21%.

About Innophos

Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.

See Also: How Investors Use a Balance Sheet

Get a free copy of the Zacks research report on Innophos (IPHS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.